Joinn Laboratories' (HKG:6127, SHA:603127) directors, including Chief Financial Officer Yu Aishui, will dispose of part of their holdings in the company, according to a Shanghai bourse disclosure on Tuesday.
Yu, along with general manager Gao Dapeng, deputy general managers Sun Yunxia and Gu Jingliang, and supervisor Li Ye, will collectively divest 848,300 shares, or 0.1132% of the company.
Currently, all directors collectively own approximately 3.4 million shares, or 0.45% of the company's shares.
The Chinese medicine development company's Hong Kong shares dropped nearly 7% and Shanghai shares fell almost 5% during midday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.